Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Is Deutsche Telekom still a target of the MMP?

No such message found

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

DesignGuy

Rank: President [?]

Points: 1726 [?]

Votes: 42 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Is Deutsche Telekom still a target of the MMP?

posted on Sep 08, 2009 04:58PM

Here are a few articles that caught my eye today and sparked thoughts about the MMP German patent, US MMP patent re-certs, and Deutsche Telekom. These are merely intended for general information on Deutsche Telekom's recent activities and I offer my apologies if this is considered a bit off-topic, but it does appear that they are being aggressive toward maintaining current and securing future market share. It would be quite welcome to see them as a licensee.

Deutsche Telekom plans massive US investments

Deutsche Telekom, France Telecom to merge UK mobile ops

Cheers,

1 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply